Literature DB >> 21732343

ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma.

Barbara Spangler1, Melanie Kappelmann, Birgit Schittek, Svenja Meierjohann, Lily Vardimon, Anja Katrin Bosserhoff, Silke Kuphal.   

Abstract

Recently, we discovered that the loss of E-cadherin induces c-Jun protein expression, which is a member of the AP-1 transcription factor family and a key player in the processes of cell proliferation and tumor development and also found in elevated levels in melanomas. Notably, the mRNA level of c-Jun was not affected, suggesting that c-Jun is regulated at post-transcriptional level. Here, we present data that suggest that the dynamic cytoskeletal network, linked to E-cadherin, is involved in the regulation of the c-Jun protein and transcriptional activity. In a signaling cascade, the loss of E-cadherin activates the transcriptional regulator ETS-1 and consequently leads to the induction of RhoC expression that stabilizes c-Jun in melanoma. The link between RhoC and c-Jun seems to be indirect via the cytoskeleton. We conclude that the loss of E-cadherin mediated cell-adhesion induces c-Jun protein expression in a multistep process, offering several possibilities for therapeutic intervention.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21732343     DOI: 10.1002/ijc.26277

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

1.  Specific c-Jun target genes in malignant melanoma.

Authors:  Patrick Schummer; Silke Kuphal; Lily Vardimon; Anja K Bosserhoff; Melanie Kappelmann
Journal:  Cancer Biol Ther       Date:  2016-04-06       Impact factor: 4.742

2.  Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation.

Authors:  Lior Blau; Revital Knirsh; Iris Ben-Dror; Sivan Oren; Silke Kuphal; Peter Hau; Martin Proescholdt; Anja-Katrin Bosserhoff; Lily Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-01       Impact factor: 11.205

3.  The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation.

Authors:  K Maurus; A Hufnagel; F Geiger; S Graf; C Berking; A Heinemann; A Paschen; S Kneitz; C Stigloher; E Geissinger; C Otto; A Bosserhoff; M Schartl; S Meierjohann
Journal:  Oncogene       Date:  2017-05-08       Impact factor: 9.867

4.  Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma.

Authors:  Jan Rožanc; Theodore Sakellaropoulos; Asier Antoranz; Cristiano Guttà; Biswajit Podder; Vesna Vetma; Nicole Rufo; Patrizia Agostinis; Vaia Pliaka; Thomas Sauter; Dagmar Kulms; Markus Rehm; Leonidas G Alexopoulos
Journal:  Cell Death Differ       Date:  2018-10-15       Impact factor: 15.828

5.  Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.

Authors:  Andrew J Haak; Kathryn M Appleton; Erika M Lisabeth; Sean A Misek; Yajing Ji; Susan M Wade; Jessica L Bell; Cheryl E Rockwell; Merlin Airik; Melanie A Krook; Scott D Larsen; Monique Verhaegen; Elizabeth R Lawlor; Richard R Neubig
Journal:  Mol Cancer Ther       Date:  2016-11-11       Impact factor: 6.261

6.  HDAC8 Regulates a Stress Response Pathway in Melanoma to Mediate Escape from BRAF Inhibitor Therapy.

Authors:  Michael F Emmons; Fernanda Faião-Flores; Ritin Sharma; Ram Thapa; Jane L Messina; Jurgen C Becker; Dirk Schadendorf; Edward Seto; Vernon K Sondak; John M Koomen; Yian A Chen; Eric K Lau; Lixin Wan; Jonathan D Licht; Keiran S M Smalley
Journal:  Cancer Res       Date:  2019-04-15       Impact factor: 12.701

7.  Activation of MAPK pathways due to DUSP4 loss promotes cancer stem cell-like phenotypes in basal-like breast cancer.

Authors:  Justin M Balko; Luis J Schwarz; Neil E Bhola; Richard Kurupi; Phillip Owens; Todd W Miller; Henry Gómez; Rebecca S Cook; Carlos L Arteaga
Journal:  Cancer Res       Date:  2013-08-21       Impact factor: 12.701

8.  Abl and Arg mediate cysteine cathepsin secretion to facilitate melanoma invasion and metastasis.

Authors:  Rakshamani Tripathi; Leann S Fiore; Dana L Richards; Yuchen Yang; Jinpeng Liu; Chi Wang; Rina Plattner
Journal:  Sci Signal       Date:  2018-02-20       Impact factor: 8.192

9.  JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma.

Authors:  Bjoern Titz; Anastasia Lomova; Allison Le; Willy Hugo; Xiangju Kong; Johanna Ten Hoeve; Michael Friedman; Hubing Shi; Gatien Moriceau; Chunying Song; Aayoung Hong; Mohammad Atefi; Richard Li; Evangelia Komisopoulou; Antoni Ribas; Roger S Lo; Thomas G Graeber
Journal:  Cell Discov       Date:  2016-09-06       Impact factor: 10.849

10.  SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.

Authors:  Shira Ashkenazi; Rona Ortenberg; Michal Besser; Jacob Schachter; Gal Markel
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.